Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR, Weiner M, Shinto L, Aisen PS. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010 Nov 3;304(17):1903-11. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Paper Alert: Negative DHA Trial Fuels Soul-Searching in AD Field
  2. Aβ Oligomers Linked to ER Stress in Patient-Derived Neurons

Therapeutics

  1. Docosahexaenoic acid (DHA)
  2. Vascepa